🇮🇹 Italy Country × Condition
breast neoplasms Clinical Trials in Italy
Active clinical trials for breast neoplasms with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇮🇹 Italy
Active Trials in Italy (3)
NCT02895165
Recruiting
PREgnancy and FERtility Registry
Enrollment
1,000 pts
Country
🇮🇹 Italy
IRCCS Azienda Ospedaliera Universit...
View Trial → NCT06608446
Recruiting
Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery
Enrollment
155 pts
Country
🇮🇹 Italy
Fondazione Policlinico Universitari...
View Trial → NCT06805812
Recruiting
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Enrollment
3,500 pts
Country
🇮🇹 Italy
Fondazione IRCCS Istituto Nazionale...
View Trial → Frequently Asked Questions
How many breast neoplasms clinical trials are active in Italy?
There are currently 3 active clinical trials for breast neoplasms with sites in Italy, of which 3 are actively recruiting patients.
How can I join a breast neoplasms clinical trial in Italy?
To join a breast neoplasms clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast neoplasms trials in Italy?
Active breast neoplasms trials in Italy span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology